65 related articles for article (PubMed ID: 19135623)
1. Genetics of hemostasis: differential effects of heritability and household components influencing lipid concentrations and clotting factor levels in 282 pediatric stroke families.
Nowak-Göttl U; Langer C; Bergs S; Thedieck S; Sträter R; Stoll M
Environ Health Perspect; 2008 Jun; 116(6):839-43. PubMed ID: 18560491
[TBL] [Abstract][Full Text] [Related]
2. Association of Valproic Acid With Central Sleep Apnea Syndrome: Two Case Reports.
Guichard K; Micoulaud-Franchi JA; McGonigal A; Coulon P; Sureau C; Ghorayeb I; Salvo F; Philip P
J Clin Psychopharmacol; 2019; 39(6):681-684. PubMed ID: 31725092
[No Abstract] [Full Text] [Related]
3. Sex differences in the susceptibility to valproic acid-associated liver injury in epileptic patients.
Ma L; Wang D
Clin Toxicol (Phila); 2024 Feb; 62(2):101-106. PubMed ID: 38512019
[TBL] [Abstract][Full Text] [Related]
4. Correction to "Overexpression of Homer1b/c induces valproic acid resistance in epilepsy".
CNS Neurosci Ther; 2024 May; 30(5):e14785. PubMed ID: 38797971
[No Abstract] [Full Text] [Related]
5. TMT-Based Proteomic Analysis of Plasma from Children with Rolandic Epilepsy.
Sun J; Jiang T; Gu F; Ma D; Liang J
Dis Markers; 2020; 2020():8840482. PubMed ID: 33082886
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant drugs and hematological disease.
Verrotti A; Scaparrotta A; Grosso S; Chiarelli F; Coppola G
Neurol Sci; 2014 Jul; 35(7):983-93. PubMed ID: 24619070
[TBL] [Abstract][Full Text] [Related]
7. Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial.
Faghihi T; Jahed A; Mahmoudi-Gharaei J; Sharifi V; Akhondzadeh S; Ghaeli P
Daru; 2012 Oct; 20(1):43. PubMed ID: 23351198
[TBL] [Abstract][Full Text] [Related]
8. Arterial thrombosis and the role of thrombophilia.
Boekholdt SM; Kramer MH
Semin Thromb Hemost; 2007 Sep; 33(6):588-96. PubMed ID: 17768691
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolism in newborns, infants and children.
Nowak-Göttl U; Kosch A; Schlegel N
Thromb Haemost; 2001 Jul; 86(1):464-74. PubMed ID: 11487037
[TBL] [Abstract][Full Text] [Related]
10. Thrombophilic risk factors in epileptic children treated with valproic Acid.
Unal O; Deda G; Teber S; Ertem M; Akar N
Pediatr Neurol; 2009 Feb; 40(2):102-6. PubMed ID: 19135623
[TBL] [Abstract][Full Text] [Related]
11. Valproate-associated coagulopathies in children during short-term treatment.
Köse G; Arhan E; Unal B; Ozaydin E; Guven A; Sayli TR
J Child Neurol; 2009 Dec; 24(12):1493-8. PubMed ID: 19482838
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
13. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
Ugras M; Yakinci C
Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilia in young patients with acute myocardial infarction.
Celik M; Altintas A; Celik Y; Karabulut A; Ayyildiz O
Saudi Med J; 2008 Jan; 29(1):48-54. PubMed ID: 18176672
[TBL] [Abstract][Full Text] [Related]
15. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
Ricart JM; Vayá A; Todolí J; Calvo J; Villa P; Estellés A; España F; Santaolaria M; Corella D; Aznar J
Thromb Haemost; 2006 Apr; 95(4):618-24. PubMed ID: 16601831
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
